
a16z Podcast
Baumol's Cost Disease, in Healthcare... and Where We Go Next
Jan 6, 2021
In this engaging discussion, Vijay Pande, a general partner at Andreessen Horowitz with a focus on biotechnology, shares his insights on the persistent challenges of Baumol's cost disease, particularly in healthcare. He and Marc Andreessen explore how technology has transformed other industries yet struggles in healthcare. They illustrate the potential of AI to reshape costs and quality, comparing innovative health apps to entertainment platforms. The conversation also touches on consumer influence in the healthcare landscape and the role of personal choices in improving health outcomes.
30:01
Episode guests
AI Chapters
Episode notes